Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

esophageal cancer

  • You have access
    Strategy Treatment of cT4b Esophageal Squamous Cell Carcinoma Using Docetaxel, Cisplatin, and 5-Fluorouracil
    MASANOBU NAKAJIMA, HIROTO MUROI, MAIKO KIKUCHI, TSUKASA KUBO, SHUHEI TAKISE, KEISUKE IHARA, MASATOSHI NAKAGAWA, SHINJI MORITA, TAKATOSHI NAKAMURA, SATORU YAMAGUCHI and KAZUYUKI KOJIMA
    Anticancer Research July 2022, 42 (7) 3725-3733; DOI: https://doi.org/10.21873/anticanres.15862
  • Open Access
    The Role of Toll-like Receptors in Esophageal Cancer
    SPYRIDON DAVAKIS, ALKISTIS KAPELOUZOU, THEODOROS LIAKAKOS, MARIA MPOURA, DIMITRIOS STERGIOU, STRATIGOULA SAKELLARIOU and ALEXANDROS CHARALABOPOULOS
    Anticancer Research June 2022, 42 (6) 2813-2818; DOI: https://doi.org/10.21873/anticanres.15762
  • You have access
    The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment
    TORU AOYAMA, MIHWA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, ITARU HASHIMOTO, KAZUKI KANO, KENTARO HARA, HARUHIKO CHO, KENKI SEGAMI, DAISUKE MACHIDA, MASATO NAKAZONO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research May 2022, 42 (5) 2711-2717; DOI: https://doi.org/10.21873/anticanres.15749
  • You have access
    Usefulness of Prophylactic Administration of Pegfilgrastim for Esophageal Cancer Chemotherapy: A Single-center Retrospective Study
    KOICHI OKAMOTO, ITASU NINOMIYA, HIROTO SAITO, MARI SHIMADA, TAKAHISA YAMAGUCHI, SHIRO TERAI, HIDEKI MORIYAMA, JUN KINOSHITA, KEISHI NAKAMURA and NORIYUKI INAKI
    Anticancer Research May 2022, 42 (5) 2783-2790; DOI: https://doi.org/10.21873/anticanres.15758
  • Open Access
    Clinical Outcomes of Radiotherapy in Elderly and Younger Patients With T4 Esophageal Cancer: A Retrospective Single-center Analysis
    YOSUKE TAKAKUSAGI, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, HIROYUKI KATOH, TADASHI KAMADA, RISA TANIUCHI, MISAKI IINO, TOMOMI AOSHIKA, SATOSHI SAITO and DAISAKU YOSHIDA
    Anticancer Research April 2022, 42 (4) 2095-2104; DOI: https://doi.org/10.21873/anticanres.15691
  • You have access
    Minimally Invasive Transcervical Esophagectomy With Mediastinal Lymphadenectomy for Cancer. A Comparison With Standardized Techniques
    SPYRIDON DAVAKIS, ALEXANDROS CHARALABOPOULOS, ELEANDROS KYROS, PANAGIOTIS SAKARELLOS, GERASIMOS TSOUROUFLIS, DIMITRIOS DIMITROULIS and NIKOLAOS NIKITEAS
    Anticancer Research February 2022, 42 (2) 675-680; DOI: https://doi.org/10.21873/anticanres.15526
  • You have access
    Pre-operative Carboplatin/Paclitaxel Versus 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer
    MOHAMMED AL-JUMAYLI, KHALIL CHOUCAIR, AMMAR AL-OBAIDI, ROBIN PARK, AJAY BANSAL, JOAQUINA BARANDA, WEIJING SUN and ANWAAR SAEED
    Anticancer Research January 2022, 42 (1) 59-66; DOI: https://doi.org/10.21873/anticanres.15457
  • You have access
    Esophageal Adenocarcinoma Metastasizing to a Solitary Fibrous Tumor: An Unprecedented Case of Tumor-to-tumor Metastasis
    UZAIR JOGIAT, CHANTALLE GRANT, ERIC L.R. BEDARD, KAROLYN AU, REMEGIO MAGLANTAY and DAVID WILLIAMS
    Anticancer Research November 2021, 41 (11) 5835-5838; DOI: https://doi.org/10.21873/anticanres.15402
  • You have access
    Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy
    YUNG-HSIN HUANG, YU-SHIN HUNG, CHENG-CHOU LAI, MING-MO HO, KUN-YUN YEH, CHIEH YANG, CHANG-HSIEN LU, CHEN-KAN TSENG, NGAN-MING TSANG, CHIA-YEN HUNG, SHUN-WEN HSUEH, PEI-HUNG CHANG, YA-WEN HO, YU-CHING LIN and WEN-CHI CHOU
    Anticancer Research October 2021, 41 (10) 5213-5222; DOI: https://doi.org/10.21873/anticanres.15340
  • You have access
    Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma
    KYOSUKE AGAWA, KIMIHIRO YAMASHITA, AKIO NAKAGAWA, KOUTA YAMADA, AKIHIRO WATANABE, JUNKO MUKOHYAMA, MASAFUMI SAITO, MITSUGU FUJITA, GOSUKE TAKIGUCHI, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, TAKERU MATSUDA, TARO OSHIKIRI, TETSU NAKAMURA, SATOSHI SUZUKI and YOSHIHIRO KAKEJI
    Anticancer Research August 2021, 41 (8) 4117-4126; DOI: https://doi.org/10.21873/anticanres.15214

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire